Industry Insights

  1. Driving Sustainability In Spray Drying Through Enabling Technologies

    By transitioning to alternative solvents or leveraging process aids, the challenges associated with the use of these chemicals can be addressed, helping create a sustainable, greener footprint.

  2. Why The Latest Technology Helps Navigate Evolving Regulator Expectations 11/27/2024

    By embracing data-driven insights, companies can confidently navigate complexities, reduce risks, and deliver trusted products to global markets.

  3. Amgen Bets On Agility In The Age Of AI 6/13/2025

    The company is speeding up process optimization with tools like predictive analytics, digital twins, and generative AI copilots.

  4. Move Beyond Manual CQV Challenges With Digital Solutions 1/24/2025

    Review how digitalizing commissioning, qualification, and validation (CQV) with a new software streamlines processes, enhances compliance, and reduces time to drive efficiency and sustainability.

  5. Shortening The Pharmaceutical Lifecycle To Provide Better, Faster Cures 12/27/2022

    We are striving to normalize a shorter timeline for drug development. Explore three areas where investments in the life sciences industry are improving outcomes and shortening development cycles.

  6. Soluble Versus Insoluble Expression In Microbial Fermentation

    Expression of inclusion bodies has historically suffered a bad reputation in the industry. So, how do these two routes, soluble and insoluble, compare in terms of their advantages and challenges?

  7. Ensure Data Integrity And Traceability Throughout The BioPharma Lifecycle 8/22/2023

    A holistic approach to data management may be the only way for BioPharma companies to gain control at every step of the product lifecycle and build the foundation for lasting competitiveness.

  8. Expert Knowledge Partners Bring Business Process Optimization to the Process Industry 4/12/2000
    It is becoming increasingly important for multinational chemical processors to improve the global integration of their supply chains...
  9. A Semi-Continuous Operations Model For Solid-Dose Manufacturing 11/1/2017

    The estimated timeline for a drug product from discovery to market is 10 to 15 years. However, less than 12 percent of drug candidates that enter clinical trials will ultimately receive FDA approval. The Orphan Drugs Act of 1983 ensured that there were adequate incentives offered to drug developers working on therapies to treat fewer than 200,000 patients in U.S.

  10. Enhancing Stability, Survival & Performance Of Microbiome-Based Products 10/16/2020

    For pharma and biotech companies focused on the development of microbiome products, it's important to develop oral dosage forms that can deliver specific formulation or application outcomes.